Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker

dc.contributor.author
Johansson, Patricia
dc.contributor.author
Laguna, Teresa
dc.contributor.author
Ossowski, Julio
dc.contributor.author
Pancaldi, Vera
dc.contributor.author
Brauser, Martina
dc.contributor.author
Dührsen, Ulrich
dc.contributor.author
Keuneke, Lara
dc.contributor.author
Queirós, Ana C.
dc.contributor.author
Richter, Julia
dc.contributor.author
Martín-Subero, José Ignacio
dc.contributor.author
Siebert, Reiner
dc.contributor.author
Schlegelberger, Brigitte
dc.contributor.author
Küppers, Ralf
dc.contributor.author
Dürig, Jan
dc.contributor.author
Murga Penas, Eva M.
dc.contributor.author
Carillo de Santa Pau, Enrique
dc.contributor.author
Bergmann, Anke K.
dc.date.issued
2023-07-26T08:06:31Z
dc.date.issued
2023-07-26T08:06:31Z
dc.date.issued
2022-11-14
dc.date.issued
2023-07-20T10:04:46Z
dc.identifier
1868-7083
dc.identifier
https://hdl.handle.net/2445/201180
dc.identifier
9332523
dc.identifier
36376973
dc.description.abstract
Background: The molecular pathogenesis of T-cell large granular lymphocytic leukemia (T-LGLL), a mature T-cell leukemia arising commonly from T-cell receptor alpha beta-positive CD8(+) memory cytotoxic T cells, is only partly understood. The role of deregulated methylation in T-LGLL is not well known. We analyzed the epigenetic profile of T-LGLL cells of 11 patients compared to their normal counterparts by array-based DNA methylation profiling. For identification of molecular events driving the pathogenesis of T-LGLL, we compared the differentially methylated loci between the T-LGLL cases and normal T cells with chromatin segmentation data of benign T cells from the BLUEPRINT project. Moreover, we analyzed gene expression data of T-LGLL and benign T cells and validated the results by pyrosequencing in an extended cohort of 17 patients, including five patients with sequential samples. Results: We identified dysregulation of DNA methylation associated with altered gene expression in T-LGLL. Since T-LGLL is a rare disease, the samples size is low. But as confirmed for each sample, hypermethylation of T-LGLL cells at various CpG sites located at enhancer regions is a hallmark of this disease. The interaction of BLC11B and C14orf64 as suggested by in silico data analysis could provide a novel pathogenetic mechanism that needs further experimental investigation. Conclusions: DNA methylation is altered in T-LGLL cells compared to benign T cells. In particular, BCL11B is highly significant differentially methylated in T-LGLL cells. Although our results have to be validated in a larger patient cohort, BCL11B could be considered as a potential biomarker for this leukemia. In addition, altered gene expression and hypermethylation of enhancer regions could serve as potential mechanisms for treatment of this disease. Gene interactions of dysregulated genes, like BLC11B and C14orf64, may play an important role in pathogenic mechanisms and should be further analyzed.
dc.format
13 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Springer Nature
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13148-022-01362-z
dc.relation
Clinical Epigenetics, 2022, vol. 14, num. 1
dc.relation
https://doi.org/10.1186/s13148-022-01362-z
dc.rights
cc by (c) Johansson, Patricia et al, 2022
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Cèl·lules T
dc.subject
Leucèmia
dc.subject
T cells
dc.subject
Leukemia
dc.title
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)